Legal Aspects of Migraine in the Workplace.

Authors:
Riggins N; Paris L.

Journal:
Curr Pain Headache Rep

Publication Year: 2022

DOI:
10.1007/s11916-022-01095-x

PMCID:
PMC9829618

PMID:
36399233

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Curr Pain Headache Rep

Abbreviation: Curr Pain Headache Rep

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Psychophysiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Acupuncture for Low Back Pain: Reevaluation of Systematic Reviews and Meta-analyses.
Yan WX; Lin HZ; Wang X and 4 more (2023) - Transparency Score: 3/6
Complex Regional Pain Syndrome (CRPS) and the Value of Early Detection.
Harnik MA; Kesselring P; Ott A and 2 more (2023) - Transparency Score: 3/6
Does Tension Headache Have a Central or Peripheral Origin? Current State of Affairs.
Repiso-Guardeño Á; Moreno-Morales N; Labajos-Manzanares MT and 2 more (2023) - Transparency Score: 3/6
Medical Cannabis for Chronic Nonmalignant Pain Management.
Hameed M; Prasad S; Jain E and 9 more (2023) - Transparency Score: 2/6
The Gut-brain Connection and Episodic Migraine: an Update.
Nguyen L; Hindiyeh N; Ray S and 2 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest Dr. Nina Riggins disclosures: consultant of Gerson Lehrman Group, Advisory Board Theranica; author Academic CME; Principal Investigator (PI) Electrocore, Theranica and Eli Lilly clinical trials; author and advisory board member at NeurologyLive; board member at “Miles for Migraine”; and uncompensated work as PI on Research Device from Dolor Technology and Theraspecs. Lorenzo Paris declares that he has no conflicts of interest."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025